Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,828,424 papers from all fields of science
Search
Sign In
Create Free Account
Tergenpumatucel-L
An allogeneic lung cancer vaccine with potential immunostimulating and antineoplastic activities. Derived from allogeneic lung tumor cells…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
NLG-0301: An open-label, randomized phase 2B active control study of second-line tergenpumatucel-L immunotherapy versus docetaxel in patients with progressive or relapsed non-small cell lung cancer…
R. Govindan
,
J. Morris
,
G. Rossi
,
N. Vahanian
,
C. Link
2014
Corpus ID: 78952085
TPS8133 Background: Tergenpumatucel-L immunotherapy consists of allogeneic lung cancer cells that have been genetically modified…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE